anti-VEGF antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-VEGF antibody, covering 2023-01-09 to 2023-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma [Phase 2]